BPA Call W81XWH19A0002-HT009024FG0210017
- Not listed
- The Defense Health Agency has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing. This $81,521.36 contract provides the agency with ForenSeq mitochondrial DNA (mtDNA) whole genome sequencing kits and consumables to support its genomic sequencing initiatives. Verogen holds a $7,433,000 single-award BPA with the Defense Health Agency, awarded in November 2023, to supply a range...
- The Defense Health Agency awarded a firm fixed price Blanket Purchase Agreement (BPA) call to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The $199,858.60 contract is for the provision of NEXTSEQ 500/550 MID sequencing systems, reagents, consumables, and technical support services to support the agency's genomic sequencing programs. Verogen has previously provided similar products and services to federal agencies such as the FBI, Army Criminal...
- This federal contract award is for the supply of REAGENT KITS to the Defense Health Agency (DHA), a component of the U.S. Department of Defense. The prime contractor is Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The contract is a Blanket Purchase Agreement (BPA) Call with a ceiling value of $88,695.32 and a performance period ending on March 27, 2025. The contract is a Firm Fixed Price arrangement and does not utilize any small business...
- This is a firm fixed price BPA call contract awarded by the Defense Health Agency to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The contract is for the delivery of MiSeq sequencing systems, ForenSeq reagent kits, next-generation sequencing reagents and consumables, and technical support services, with a potential value of $117,480.37. Verogen has previously provided similar products and services to federal agencies such as the FBI, Army...
- This contract award to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing, was made by the Defense Health Agency. The $45,483.03 firm-fixed-price contract provides for the delivery of ForenSeq Kintelligence KT reagents, which are used in next-generation DNA sequencing systems. This is a Blanket Purchase Agreement (BPA) call, part of a larger $7,433,000 single-award BPA that Verogen holds with the Defense Health Agency. The BPA allows the agency...
- This firm fixed-price contract award to Verogen, Inc. by the Defense Health Agency is a BPA call order valued at $225,050.22. It does not have a set-aside designation. The contract is for the procurement of MiSeq RGT KIT V3 (150) sequencing reagents and consumables to support the agency's genomic sequencing programs. Verogen is a biotechnology company that specializes in forensic genomics and DNA sequencing, and has previously provided similar products and services to federal agencies such as...
- This is a federal contract award to Verogen, Inc., a biotechnology company specializing in forensic genomics and DNA sequencing. The award, valued at $93,198.80, was issued by the Defense Health Agency (DHA) and provides for the procurement of Illumina reagents and consumables through a Blanket Purchase Agreement (BPA) call. The contract does not have a small business set-aside designation. Verogen, as the prime contractor, will supply the DHA with its MiSeq FGx sequencing systems, ForenSeq...
- This is a firm fixed price contract awarded by the Defense Health Agency to Verogen, Inc., a biotechnology research company that specializes in forensic genomics and DNA sequencing. The contract has a potential value of $235,984.48 and does not have a set-aside designation. Through this contract, Verogen will provide the Defense Health Agency with various products and services related to next-generation DNA sequencing, including MiSeq FGx sequencing systems, ForenSeq reagent kits, sequencing...
- This is a firm fixed price contract awarded by the Defense Health Agency (DHA) to Verogen, Inc., a biotechnology company that specializes in forensic genomics and DNA sequencing. The contract is for the delivery of 200 units of the MiSeq RGT KT V3 (150) reagent kit, valued at $237,552.00. Verogen has provided similar sequencing systems, reagents, and technical services to federal agencies like the FBI, Army Criminal Investigation Command, and National Institute of Standards and Technology...
- This federal contract award was issued by the Defense Health Agency to Verogen, Inc., a biotechnology research company specializing in forensic genomics and DNA sequencing. The $92,962.80 Firm Fixed Price contract is for the delivery of MiSeq Reagent Kits (150 Cycle) under a Blanket Purchase Agreement call. The contract has no set-aside designation and was awarded on December 13, 2018 with a completion date of January 4, 2019. Verogen is an experienced prime contractor and subcontractor that has...
- W81XWH19A0002Blanket Purchase Agreement
- W81XWH19A0002-HT009024FG0210017BPA Call
The Defense Health Agency (DHA) has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call to Verogen, Inc. for the provision of testing reagents and consumables to support the agency's genomic sequencing initiatives. The contract, valued at $46,967.19, is for the delivery of products such as MiSeq reagent kits, NextSeq systems, and ForenSeq kits. This BPA, which has no set-aside designation, was originally awarded to Verogen in November 2023 and runs through October 2028. Verogen, a foreign-owned, for-profit biotechnology company, has previously partnered with agencies like the Federal Bureau of Investigation, Army Criminal Investigation Command, and National Institute of Standards and Technology to support their DNA analysis and genomic sequencing programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.0k | 2/28/24 |